Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› SongpaGu
Clinical trial register · South Korea

Clinical Trials in SongpaGu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3401 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
3401
Studies in scope
all four open statuses
1867
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Seoul 2859 Daegu 553 Seongnam-si 482 Busan 469 Goyang-si 397
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in SongpaGu

23 of 3401 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
BeOne Medicines
Phase 3
500
Seongnam-si, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2026-01-22
Recruiting
BeOne Medicines
Phase 3
351
Seongnam-si, BukGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-08-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Hwasun Gun, Seocho-gu, Songpagu, Donggu, Seoul
2025-05-13
Recruiting
BeOne Medicines
Phase 3
300
Seogu, GangnamGu, SeochoGu, Seoul, SongpaGu, Yeongdeungpo-gu
2025-03-05
Recruiting
BeOne Medicines
Phase 1
695
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-01-10
Recruiting
BeOne Medicines
Phase 1
168
BundangGu SeongnamSi, Seongnam-si, BukGu, NamdongGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2024-12-09
Recruiting
BeOne Medicines
Phase 1
153
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2024-10-18
Recruiting
BeOne Medicines
Phase 1
310
Seongnam-si, GangnamGu, SeodaemunGu, SongpaGu
2024-10-03
Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
NCT06427941Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Extragonadal Yolk Sac Tumors
BeOne Medicines
Phase 1/2
630
Cheongju-si, BundangGu SeongnamSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2024-07-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Songpagu, Seoul
2023-12-31
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
BeOne Medicines
Phase 1
433
Seongnam-si, NamdongGu, GangnamGu, SeochoGu, SeodaemunGu, SeongbukGu, Seoul, SongpaGu
2023-12-01
Active, closed
BeOne Medicines
Phase 3
652
IlsandongGu GoyangSi, Seongnam-si, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2023-11-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Goyang-si, Seongnam, Songpagu, Seoul
2022-03-15
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
689
Seogu, GangnamGu, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2021-09-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Songpagu, Seoul
2018-12-24
Active, closed
Eli Lilly and Company
Phase 2/3
393
Seoul, Songpagu
2018-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Inceon, Hwasun, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Gangnam-gu, Songpagu
2018-08-21
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/songpagu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,401 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in SongpaGu.

How many clinical trials are recruiting in SongpaGu?

15 of the 23 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (SongpaGu), 23 studies
PhaseStudiesRecruitingShare
Phase 312652.2%
Phase 15521.7%
Phase 1/25421.7%
Phase 2/3104.3%

Most active sponsors

Lead sponsors with the most studies (SongpaGu)
Lead sponsorStudiesRecruiting
BeOne Medicines1211
Merck Sharp & Dohme LLC104
Eli Lilly and Company10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.